These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 8257518)

  • 1. Re: R. Peto et al., Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: a detailed dose-response study. Cancer Res., 51: 6415-6451, 1991, and K. S. Crump et al., Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res., 36: 2973-2979, 1976.
    Stöhrer G
    Cancer Res; 1993 Sep; 53(17):4107-8. PubMed ID: 8257518
    [No Abstract]   [Full Text] [Related]  

  • 2. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the carcinogenicity of 1,1-dichloroethylene (vinylidene chloride).
    Roberts SM; Jordan KE; Warren DA; Britt JK; James RC
    Regul Toxicol Pharmacol; 2002 Feb; 35(1):44-55. PubMed ID: 11846635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
    Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hazard identification and dose response of ingested nickel-soluble salts.
    Haber LT; Diamond GL; Zhao Q; Erdreich L; Dourson ML
    Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):231-41. PubMed ID: 10854128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrobenzene potential human cancer risk based on animal studies.
    Holder JW
    Toxicol Ind Health; 1999 Aug; 15(5):458-63. PubMed ID: 10487356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of in vivo mutation data can inform cancer risk assessment.
    Moore MM; Heflich RH; Haber LT; Allen BC; Shipp AM; Kodell RL
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):151-61. PubMed ID: 18321622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
    Sanner T; Dybing E; Willems MI; Kroese ED
    Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal carcinogenicity studies: implications for the REACH system.
    Knight A; Bailey J; Balcombe J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():139-47. PubMed ID: 16555967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic data and cancer risk assessment: the need for quantitative molecular endpoints.
    Preston RJ
    Environ Mol Mutagen; 2005; 45(2-3):214-21. PubMed ID: 15645441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reaction on Gargas et al.: Acrylamide: consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion.
    Hogervorst J; Schouten L; van den Brandt P
    Food Chem Toxicol; 2009 Nov; 47(11):2871-2; author reply 2873-4. PubMed ID: 19682529
    [No Abstract]   [Full Text] [Related]  

  • 13. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine.
    Swenberg JA; Hoel DG; Magee PN
    Cancer Res; 1991 Dec; 51(23 Pt 2):6409-14. PubMed ID: 1933905
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of thresholds for carcinogenicity.
    Waddell WJ
    Toxicol Lett; 2004 Apr; 149(1-3):415-9. PubMed ID: 15093289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cancer slope factors using different statistical approaches.
    Subramaniam RP; White P; Cogliano VJ
    Risk Anal; 2006 Jun; 26(3):825-30. PubMed ID: 16834636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of diesel-exhaust unit-risk estimates derived from animal bioassays.
    Valberg PA; Watson AY
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):30-44. PubMed ID: 8921544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between the data bases, statistical analyses, and interpretations of lung tumors of the 19-dust study: two controversial views.
    Roller M
    Exp Toxicol Pathol; 2007 Aug; 58(6):393-405. PubMed ID: 17560774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal studies in potency ranking of carcinogens in Norway.
    Sanner T; Dybing E; Hardeng S; Haug E; Ovrebø S
    Prog Clin Biol Res; 1992; 374():399-414. PubMed ID: 1620715
    [No Abstract]   [Full Text] [Related]  

  • 20. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.